Meningitis B Vaccine Programme Expanded in Kent Following Outbreak
Health Secretary Wes Streeting visited the University of Kent on Thursday to announce a significant expansion of the meningitis B vaccination programme in response to a local outbreak. The move aims to protect more individuals, particularly students and close contacts of confirmed cases, as health officials work to contain the spread.
Eligibility and Scope of the Expansion
During his visit to the Canterbury campus, Wes Streeting detailed that the menB jab will now be offered to a broader group. This includes anyone who attended Club Chemistry from March 5 until its closure, who are urged to come forward for both the vaccine and prophylactic antibiotics. Additionally, the expansion covers individuals previously offered the antibiotic, such as students at the University of Kent and some from Canterbury Christchurch University.
The programme will also extend to sixth form pupils at four schools where known or suspected cases of menB have been identified. The University of Kent has confirmed that all students and staff are now eligible, with a vaccination clinic operational in the sports centre to facilitate access.
Vaccination Progress and Wider Calls for Action
According to Mr Streeting, more than 600 vaccinations were administered on the first afternoon of the expanded programme, with thousands more students expected to be offered the jab in the coming days. However, there are currently no plans for a nationwide catch-up programme at universities.
Despite this, 40 MPs have signed a letter addressed to the Health Secretary, urging the Government and health officials to collaborate with universities across the country on catch-up vaccination initiatives and to enhance public awareness. The letter also emphasised the need for the Joint Committee on Vaccination and Immunisation (JCVI) to expedite its review of eligibility criteria for meningitis vaccines. Club Chemistry owner Louise Jones-Roberts has advocated for extending the vaccine to all individuals under 25.
Outbreak Details and Risk Assessment
As of 5pm on Wednesday, 15 cases of meningitis B had been confirmed, with an additional 12 under investigation, bringing the total to 27—up from 20 previously reported. Mr Streeting warned that more cases are anticipated in the coming days, noting that menB has an incubation period of seven to ten days. He also highlighted that other regions may report unrelated cases, as there are typically at least 350 cases of menB annually in the UK.
Regarding the risk of further spread, the Health Secretary reassured the public that the outbreak "isn't like Covid," and the risk to the general population remains "extremely low." Meningitis B primarily spreads through prolonged close contact or intimate activities such as kissing, limiting its transmission compared to respiratory viruses.
Logistical Considerations and Vaccine Efficacy
For students who have already left campus and returned home before receiving the jab, arrangements are being developed to allow them to obtain the vaccine through their GP, though specifics remain unclear at this stage.
The vaccine most likely to be used in this targeted programme, Bexsero, protects against up to 80% of menB strains. Some immunity develops approximately two weeks after the first dose, but full protection requires two doses, with a recommended interval of at least four weeks between them. Experts caution that while the jab will "greatly increase students' immunity to most menB strains," it does not provide immediate protection. In Kent, the two-dose course is being administered alongside antibiotics as an additional precautionary measure.
Protection from the vaccine can last for years after completion of the two-dose regimen, with some estimates suggesting immunity may persist for up to 36 months.
Symptoms and Public Health Advice
Symptoms of meningitis and sepsis include a high temperature, cold hands and feet, vomiting, confusion, muscle and joint pain, pale or blotchy skin, spots or a rash, headache, stiff neck, sensitivity to bright lights, excessive sleepiness, and seizures. The UK Health Security Agency (UKHSA) advises anyone experiencing these symptoms to seek medical assistance promptly by contacting their GP or calling NHS 111.
